Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis
by
Kazantzis Dimitrios
, Sergentanis, Theodoros N
, Theodossiadis, Panagiotis G
, Chatzirallis, Alexandros P
, Psaltopoulou Theodora
, Machairoudia Genovefa
, Papageorgiou, Effie G
, Chatziralli, Irini P
, Theodossiadis, George P
in
Cholesterol
/ Diabetes
/ Diabetes mellitus
/ Diabetic neuropathy
/ Dyslipidemia
/ Health care
/ High density lipoprotein
/ Hypercholesterolemia
/ Hypertension
/ Ischemia
/ Low density lipoprotein
/ Meta-analysis
/ Metabolic disorders
/ Ophthalmology
/ Optic neuropathy
/ Regression analysis
/ Risk factors
/ Systematic review
/ Triglycerides
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis
by
Kazantzis Dimitrios
, Sergentanis, Theodoros N
, Theodossiadis, Panagiotis G
, Chatzirallis, Alexandros P
, Psaltopoulou Theodora
, Machairoudia Genovefa
, Papageorgiou, Effie G
, Chatziralli, Irini P
, Theodossiadis, George P
in
Cholesterol
/ Diabetes
/ Diabetes mellitus
/ Diabetic neuropathy
/ Dyslipidemia
/ Health care
/ High density lipoprotein
/ Hypercholesterolemia
/ Hypertension
/ Ischemia
/ Low density lipoprotein
/ Meta-analysis
/ Metabolic disorders
/ Ophthalmology
/ Optic neuropathy
/ Regression analysis
/ Risk factors
/ Systematic review
/ Triglycerides
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis
by
Kazantzis Dimitrios
, Sergentanis, Theodoros N
, Theodossiadis, Panagiotis G
, Chatzirallis, Alexandros P
, Psaltopoulou Theodora
, Machairoudia Genovefa
, Papageorgiou, Effie G
, Chatziralli, Irini P
, Theodossiadis, George P
in
Cholesterol
/ Diabetes
/ Diabetes mellitus
/ Diabetic neuropathy
/ Dyslipidemia
/ Health care
/ High density lipoprotein
/ Hypercholesterolemia
/ Hypertension
/ Ischemia
/ Low density lipoprotein
/ Meta-analysis
/ Metabolic disorders
/ Ophthalmology
/ Optic neuropathy
/ Regression analysis
/ Risk factors
/ Systematic review
/ Triglycerides
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis
Journal Article
Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis
2022
Request Book From Autostore
and Choose the Collection Method
Overview
Abstract PurposeThe purpose of this systematic review and meta-analysis of the literature is to evaluate the association between cardiometabolic risk factors (hypertension, diabetes mellitus, hypercholesterolemia/dyslipidemia, HDL cholesterol, LDL cholesterol, lipoprotein(a), and triglycerides) and non-arteritic anterior ischemic optic neuropathy (NAION).MethodsPertinent publications were identified through a systematic search in PubMed and EMBASE databases, without language restrictions. The pooled odds ratios (OR) and standardized mean differences (SMD), with their 95% confidence intervals (95% CI) were estimated using random effects (DerSimonian Laird) models, as appropriate. A set of subgroup analyses and meta-regression analysis models were performed.ResultsTwenty-one studies (including 1560 patients with NAION and 2292 controls), examining the association between NAION and cardiometabolic risk factors, were eligible for the systematic review and meta-analysis. Hypertension (pooled OR = 1.50; 95% CI: 1.16–1.94), diabetes mellitus (pooled OR = 1.71; 95% CI: 1.33–2.21), and hypercholesterolemia/dyslipidemia (pooled OR = 2.00; 95% CI: 1.53–2.62) were associated with NAION. Among the components of dyslipidemia, higher serum triglycerides were associated with NAION, with a medium effect size (SMD = + 0.58, 95% CI: + 0.12 to + 1.04), whereas synthesis of four studies reporting on HDL and LDL cholesterol did not reveal any significant associations. A significant association between NAION and higher serum lipoprotein(a) levels (pooled OR = 2.88; 95%CI: 1.01–8.21) was also noted.ConclusionsThis systematic review and meta-analysis found that NAION was associated with cardiometabolic factors, suggesting that vascular dysfunction may be implicated in the pathogenesis of the disease. Our findings may alert health care providers to try modifying these risk factors for NAION prevention.
This website uses cookies to ensure you get the best experience on our website.